Evidence map›Paper›PMID 28406539›Full record

ArticleBritish journal of clinical pharmacology2017

Mechanisms of drug-drug interaction between rifampicin and fusidic acid.

Florianne Bel, Laurent Bourguignon, Michel Tod, Tristan Ferry, Sylvain Goutelle

Abstract readLetterComment
In one paragraph

Article in British journal of clinical pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Mechanisms of fusidic acid resistance.Biochemical Society transactions · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Mechanisms of drug-drug interaction between rifampicin and fusidic acid.British journal of clinical pharmacology · 2017
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Florianne BelHospices Civils de Lyon, Groupement Hospitalier Nord, Service Pharmaceutique, Lyon, France.
Laurent BourguignonHospices Civils de Lyon, Groupement Hospitalier Nord, Service Pharmaceutique, Lyon, France.
Michel TodHospices Civils de Lyon, Groupement Hospitalier Nord, Service Pharmaceutique, Lyon, France.
Tristan FerryDepartment of Infectious Diseases, Hospices Civils de Lyon, Lyon, France.
Sylvain GoutelleHospices Civils de Lyon, Groupement Hospitalier Nord, Service Pharmaceutique, Lyon, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Fusidic AcidRifampinAnti-Bacterial AgentsDrug InteractionsHumansMicrobial Sensitivity TestsStaphylococcal InfectionsAnti-Bacterial AgentsFusidic AcidRifampin

Identifiers

PMID28406539
PMCPMC5510078

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.